EFM
REGN icon

E Fund Management’s Regeneron Pharmaceuticals REGN Stock Holding History

E Fund Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.22M Buy
5,158
+333
+7% +$227K 0.07% 121
2026
Q1 		$3.73M Buy
+4,825
New +$3.69M 0.11% 98
2025
Q2 		$2.8M Buy
5,329
+417
+8% +$233K 0.13% 95
2025
Q1 		$3.12M Buy
4,912
+1,714
+54% +$1.18M 0.15% 96
2024
Q4 		$2.28M Buy
3,198
+929
+41% +$780K 0.11% 101
2024
Q3 		$2.39M Sell
2,269
-70
-3% -$77.9K 0.12% 84
2024
Q2 		$2.46M Buy
2,339
+646
+38% +$626K 0.14% 73
2024
Q1 		$1.63M Sell
1,693
-118
-7% -$112K 0.1% 85
2023
Q4 		$1.59M Sell
1,811
-22
-1% -$18.1K 0.1% 65
2023
Q3 		$1.51M Buy
1,833
+113
+7% +$88.8K 0.11% 67
2023
Q2 		$1.24M Sell
1,720
-85
-5% -$65.5K 0.1% 68
2023
Q1 		$1.48M Sell
1,805
-128
-7% -$96.5K 0.11% 68
2022
Q4 		$1.4M Sell
1,933
-201
-9% -$148K 0.12% 70
2022
Q3 		$1.47M Sell
2,134
-49
-2% -$30.8K 0.14% 70
2022
Q2 		$1.29M Buy
2,183
+375
+21% +$244K 0.12% 77
2022
Q1 		$1.26M Buy
1,808
+141
+8% +$89.2K 0.04% 72
2021
Q4 		$1.05M Buy
1,667
+5
+0.3% +$3.07K 0.04% 105
2021
Q3 		$1.01M Buy
+1,662
New +$1.03M 0.04% 91
2021
Q1 		$821K Buy
+1,736
New +$845K 0.07% 102

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

E Fund Management's REGN Position: Q2 2026 in Review

E Fund Management increased its Regeneron Pharmaceuticals (REGN) stake by 6.9% in Q2 2026, buying an estimated $227K and bringing the position to 5,158 shares worth $3.22M. The position accounts for 0.07% of the portfolio, ranked #121.

E Fund Management first reported a position in REGN in Q1 2021 and has held it in 19 quarters since. The position peaked at $3.73M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • E Fund Management held 5,158 shares of Regeneron Pharmaceuticals worth $3.22M as of Q2 2026.
  • E Fund Management bought 333 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $227K.
  • Regeneron Pharmaceuticals made up 0.07% of E Fund Management's portfolio in Q2 2026, its #121 holding.
  • E Fund Management first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 19 quarters since.
  • E Fund Management's Regeneron Pharmaceuticals position peaked at $3.73M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.